Miles Davenport

Professor

UNSW Sydney

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (9)

Adam K. Wheatley

University of Melbourne

AUSTRALIA

View details

David S. Khoury

University of New South Wales

AUSTRALIA

View details

Megan Steain

University of Sydney

AUSTRALIA

View details

Hyon Xhi Tan

University of Melbourne

AUSTRALIA

View details

E John Wherry

Professor

University of Pennsylvania

UNITED STATES

View details

Kanta Subbarao

Professor

University of Melbourne

AUSTRALIA

View details

Stephen J. Kent

University of Melbourne

AUSTRALIA

View details

Henrik Kløverpris

Københavns Universitet

DENMARK

View details

Jennifer A Juno

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miles Davenport

Research Interests

Explore related searches

Contact this professor

Articles (10)

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis

Predicting the efficacy of variant-modified COVID-19 vaccine boosters

Early microbial exposure shapes adult immunity by altering CD8+ T cell development

Nice and slow make the germinal centers go: measured and escalating antigen delivery enhance durability and quality of humoral immune responses against HIV‐1

Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?

Establishment and recall of SARS-CoV-2 spike epitope-specific CD4<sup>+</sup> T cell memory.

Balancing statistical power and risk in HIV cure clinical trial design.

Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial.

Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice.

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.

Collaborators (9)

Adam K. Wheatley

David S. Khoury

Megan Steain

Hyon Xhi Tan

E John Wherry

Kanta Subbarao

Stephen J. Kent

Henrik Kløverpris

Jennifer A Juno

Make your next move.